{"id":7288,"date":"2017-10-12T18:19:17","date_gmt":"2017-10-12T18:19:17","guid":{"rendered":"http:\/\/faceinews.com\/?p=7288"},"modified":"2017-10-12T18:19:17","modified_gmt":"2017-10-12T18:19:17","slug":"dr-mohans-diabetes-specialities-centre-launches-precision-diabetes","status":"publish","type":"post","link":"https:\/\/www.faceinews.com\/?p=7288","title":{"rendered":"Dr. Mohan\u2019s Diabetes Specialities Centre launches \u2018Precision Diabetes\u2019"},"content":{"rendered":"
\"Media<\/a><\/b><\/span><\/span><\/span><\/div>\n
<\/div>\n
Photo Caption:<\/b>\u00a0<\/span><\/span><\/span>Dr. Mohan\u2019s Diabetes Specialties Centre inaugurating \u2018Precision Diabetes’<\/span><\/div>\n
\u00a0<\/span><\/div>\n
(L-R) Dr. R. M. Anjana,\u00a0<\/span><\/span>Director and Diabetologist<\/span>,\u00a0<\/span><\/span><\/span>Director,\u00a0<\/b><\/span>Madras Diabetes Research Foundation<\/span><\/span>\u00a0; Dr. V. Mohan,\u00a0<\/span>Chairman & Chief Diabetologist, Dr. Mohan’s Diabetes Specialities Centre; Mr. Bharat Joshi\u00a0\u00a0<\/span><\/span><\/span>Deputy High Commissioner at British Deputy High Commission, Chennai; Prof. Colin Palmer\u00a0<\/span>Chair of Pharmacogenomics at\u00a0<\/span><\/u><\/u>University of Dundee<\/u>,\u00a0<\/u>Scotland<\/u><\/u>.\u00a0<\/span><\/div>\n
<\/div>\n
\"Faceinews<\/a><\/div>\n
\n

First diabetes centre in India to introduce \u2018Precision (personalized) Diabetes\u2019 department\u00a0 <\/em><\/strong><\/p>\n

National:<\/strong> India\u2019s leading diabetes experts, Dr. Mohan\u2019s Diabetes Specialties Centre (DMDSC) announced the launch of \u2018Precision (Personalized)\u00a0 Diabetes Department\u2019<\/strong>– paving the way for a revolutionary approach to managing diabetes. Always ahead of the curve, DMDSC would be the first center to introduce \u2018Precision Diabetes\u2019 in India. The department was inaugurated by Mr. Bharat Joshi<\/strong>, Deputy High Commissioner at British Deputy High Commission, Chennai in the presence of Prof. Colin Palmer<\/strong>, Chair of Pharmacogenomics at University of Dundee, Scotland.<\/p>\n

The \u2018Precision\u00a0 (personalized)\u00a0 <\/strong>Diabetes\u2019 department has been launched to coincide with the launch of a major Indo-UK research collaboration on diabetes between the Madras Diabetes Research<\/strong> Foundation (MDRF), <\/strong>Chennai and \u00a0the University of Dundee<\/strong>, Scotland. The INDO-UK collaborative project is under the National Institute of Health Research (NIHR) Global Health Research programme with Prof. Colin Palmer<\/strong> from University of Dundee as the lead from UK and Dr.V.Mohan<\/strong> and colleagues from MDRF as the lead from India.<\/p>\n

At its core, precision is a model that proposes customized of health care with medical practices, testing, decisions and treatments tailored to the individual patient level. Diagnostic tests and therapies are selected not only on the basis of generic symptoms but also by the specific risk factor profile and health history obtained from genetic or clinical profiling.<\/p>\n

Diabetes is a complex health condition where symptoms differ from person to person and so does the diagnosis. Present day refinements in technology and advancements in genomics and other fields has proved that there are at least 20 types of diabetes that exists. Applying these principles of \u2018Precision Diabetes\u2019 will make it possible to accurately classify a patient and determine the type of diabetes any individual is suffering from depending on which the treatment for the patient will be prescribed.<\/p>\n

Speaking about the launch Dr. V Mohan, Chairman & Chief Diabetologist, Dr. Mohan’s Diabetes Specialities Centre <\/strong>said, \u201cPrecision Diabetes in the Indian context will be revolutionary. Indians are predisposed to diabetes and with a change in the profile of patients diagnosed each, we cannot adopt a one size fits all approach. At Dr. Mohan\u2019s Diabetes Specialities Centre, we constantly try to innovate and provide the best diabetes care to our patients, launch of \u2018Precision Diabetes\u2019 is another step towards it. The Precision Diabetes (Personalized) Department has been established<\/em> with the aim to promote the translation of basic science into patient treatments. We have found the genetic mutation \/genetic cause for Neonatal Diabetes and Maturity Onset of Diabetes in Youth (MODY) in India as we are recognized by ICMR as Nodal centre for genetic screening of monogenic diabetes. Many patients with these conditions who were wrongly diagnosed to have type 1 diabetes need lifelong insulin injections have been shifted to oral Sulphonylurea drug and are doing very well.\u00a0 That is a dramatic achievement. This is one example of Precision Diabetes. We hope to achieve many such breakthroughs in diabetes through this department. We believe this approach will not only provide accurate and relevant treatment, but also have a huge impact on the cost of managing diabetes<\/em>\u201d<\/p>\n

Adding to this, Prof. Colin Palmer, Chair of Pharmacogenomics at <\/strong>University<\/strong> of Dundee<\/strong> said, \u201cWith increasing industrialization and westernization the number of individuals with diabetes are rapidly increasing. Thus, there is an urgent need for a large in-depth study of the specific causes and consequences of diabetes in India in order to identify different subtypes of diabetes that exist in India and understand how best to manage each subtype. This project will address that. It will also look at new ways of providing diabetes screening, using smartphone technology and retinal scans, which will provide valuable insights into how we can deliver more cost-effective and affordable diagnosis and treatment of diabetes. The project commands access to two of the most sophisticated shared electronic patient record for every individual with type 2 diabetes \u00a0in the world: the Scottish Clinical Care Information- Diabetes Care (SCI-DC) and the Dr Mohan\u2019s Specialities Diabetes Centre, together, amounting in total to over 650,000 patients with diabetes with continuous data spanning over 20 years.<\/em> Working with Dr Mohan\u2019s team, the project will also examine the potential for delivering next-generation telemedicine for diabetes screening in the rural communities of Tamilnadu\u201d.<\/em><\/p>\n

\u2018Precision Diabetes\u2019 will be available at Dr. Mohan\u2019s Diabetes Specialities Centre, No.6B,Conran Smith Road, Gopalapuram, Chennai 600086 and soon at all its branches.<\/p>\n

About Dr. Mohan\u2019s Diabetes Specialties C<\/strong>entre:<\/strong><\/p>\n

Dr. Mohan\u2019s Diabetes Specialties Centre is a diabetes speciality chain founded in the year 1991 headquartered in Chennai, Tamil Nadu. It is one of India\u2019s leading diabetes care providers offering comprehensive services for diabetes patients. Dr. Mohan’s Diabetes Specialties Centres now has 35 diabetes centres and clinics in India (9 centres in Chennai, 2 centres in Vellore & Gudiyatham, 5 centres in Hyderabad, 4 Centres in Bengaluru, 2 centres in Kerala and 1 centre each in Mysuru, Mangalore, Coimbatore, Madurai, Pondicherry, Chunampet, Thanjavur, Vijayawada, New Delhi, Bhubaneswar, Lucknow, Tuticorin and Vishakhapatnam) and over 4 lakh diabetic patients have been registered at these centres. The centre specializes in Total Diabetes Care, Diabetes Eye Care, Diabetes Foot Care services, Diabetes Cardiac Care, Diabetes Dental Care, Preventive Care, Diet counselling and an advanced laboratory. Appointments can be booked online at www.drmohans.com<\/a> or24x7\u00a0\u00a0\u00a0\u00a0 at 920920 0091.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Photo Caption:\u00a0Dr. Mohan\u2019s Diabetes Specialties Centre inaugurating \u2018Precision Diabetes’ \u00a0 (L-R) Dr. R. M. Anjana,\u00a0Director and Diabetologist,\u00a0Director,\u00a0Madras Diabetes Research Foundation\u00a0; Dr. V. Mohan,\u00a0Chairman & Chief Diabetologist, Dr. Mohan’s Diabetes Specialities Centre; Mr. Bharat Joshi\u00a0\u00a0Deputy High Commissioner at British Deputy High Commission, Chennai; Prof. Colin Palmer\u00a0Chair of Pharmacogenomics at\u00a0University of Dundee,\u00a0Scotland.\u00a0 First diabetes centre in India […]<\/p>\n","protected":false},"author":2,"featured_media":7289,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[31],"tags":[],"class_list":["post-7288","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health"],"_links":{"self":[{"href":"https:\/\/www.faceinews.com\/index.php?rest_route=\/wp\/v2\/posts\/7288","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.faceinews.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.faceinews.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.faceinews.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.faceinews.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=7288"}],"version-history":[{"count":1,"href":"https:\/\/www.faceinews.com\/index.php?rest_route=\/wp\/v2\/posts\/7288\/revisions"}],"predecessor-version":[{"id":7290,"href":"https:\/\/www.faceinews.com\/index.php?rest_route=\/wp\/v2\/posts\/7288\/revisions\/7290"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.faceinews.com\/index.php?rest_route=\/wp\/v2\/media\/7289"}],"wp:attachment":[{"href":"https:\/\/www.faceinews.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=7288"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.faceinews.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=7288"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.faceinews.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=7288"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}